Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26

被引:192
|
作者
Chiu, David Kung-Chun [1 ]
Xu, Iris Ming-Jing [1 ]
Lai, Robin Kit-Ho [1 ]
Tse, Aki Pui-Wah [1 ]
Wei, Larry Lai [1 ]
Koh, Hui-Yu [1 ]
Li, Lynna Lan [1 ]
Lee, Derek [1 ]
Lo, Regina Cheuk-Lam [1 ,2 ]
Wong, Chun-Ming [1 ,2 ]
Ng, Irene Oi-Lin [1 ,2 ]
Wong, Carmen Chak-Lui [1 ,2 ]
机构
[1] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China
关键词
ATRIAL-FIBRILLATION; DIGOXIN; ANGIOGENESIS; SUBSETS; ENTRY;
D O I
10.1002/hep.28655
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A population of stromal cells, myeloid-derived suppressor cells (MDSCs), is present in tumors. Though studies have gradually revealed the protumorigenic functions of MDSCs, the molecular mechanisms guiding MDSC recruitment remain largely elusive. Hypoxia, O-2 deprivation, is an important factor in the tumor microenvironment of solid cancers, whose growth often exceeds the growth of functional blood vessels. Here, using hepatocellular carcinoma as the cancer model, we show that hypoxia is an important driver of MDSC recruitment. We observed that MDSCs preferentially infiltrate into hypoxic regions in human hepatocellular carcinoma tissues and that hypoxia-induced MDSC infiltration is dependent on hypoxia-inducible factors. We further found that hypoxia-inducible factors activate the transcription of chemokine (C-C motif) ligand 26 in cancer cells to recruit chemokine (C-X3-C motif) receptor 1-expressing MDSCs to the primary tumor. Knockdown of chemokine (C-C motif) ligand 26 in cancer cells profoundly reduces MDSC recruitment, angiogenesis, and tumor growth. Therapeutically, blockade of chemokine (C-C motif) ligand 26 production in cancer cells by the hypoxia-inducible factor inhibitor digoxin or blockade of chemokine (C-X3-C motif) receptor 1 in MDSCs by chemokine (C-X3-C motif) receptor 1 neutralizing antibody could substantially suppress MDSC recruitment and tumor growth. Conclusion: This study unprecedentedly reveals a novel molecular mechanism by which cancer cells direct MDSC homing to primary tumor and suggests that targeting MDSC recruitment represents an attractive therapeutic approach against solid cancers. (Hepatology 2016;64:797-813)
引用
收藏
页码:797 / 813
页数:17
相关论文
共 50 条
  • [21] Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
    Tao, Huimin
    Liu, Mingyu
    Wang, Yuan
    Luo, Shufeng
    Xu, Yongquan
    Ye, Bin
    Zheng, Limin
    Meng, Kun
    Li, Lian
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] C-C chemokine receptor 2-positive monocytic myeloid-derived suppressor cells predicts chemotherapeutic responses of the metastatic lesions in breast cancer patients
    Kim, Ju Won
    Sa, Jason K.
    Jung, Seung Pil
    Park, Kyong Hwa
    Park, Serk In
    CANCER RESEARCH, 2023, 83 (07)
  • [23] CLINICAL ASSOCIATIONS WITH MYELOID-DERIVED SUPPRESSOR CELL (MDSC) LEVELS IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS
    Franke, K.
    Yu, L.
    Apodaca, M.
    Yeung, R.
    Harris, W.
    Morishima, C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (01) : 185 - 185
  • [24] Impact of myeloid-derived suppressor cell on Kupffer cells from mouse livers with hepatocellular carcinoma
    Lacotte, Stephanie
    Slits, Florence
    Orci, Lorenzo A.
    Meyer, Jeremy
    Oldani, Graziano
    Delaune, Vaihere
    Gonelle-Gispert, Carmen
    Morel, Philippe
    Toso, Christian
    ONCOIMMUNOLOGY, 2016, 5 (11):
  • [25] CLINICAL ASSOCIATIONS WITH MYELOID-DERIVED SUPPRESSOR CELL (MDSC) LEVELS IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS
    Franke, Kathryn A.
    Yu, Lei
    Apodaca, Minjun C.
    Yeung, Raymond S.
    Harris, William P.
    Morishima, Chihiro
    HEPATOLOGY, 2020, 72 : 661A - 661A
  • [26] Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo
    Wang, Weilin
    Huang, Pengfei
    Zhang, Lufei
    Wei, Jianfeng
    Xie, Qingsong
    Sun, Qiang
    Zhou, Xiaohu
    Xie, Haiyang
    Zhou, Lin
    Zheng, Shusen
    CANCER SCIENCE, 2013, 104 (11) : 1523 - 1531
  • [27] Role of chemokine (C-C motif) ligand 24 in spatial arrangement of the inner cell mass of the bovine embryo
    Negron-Perez, Veronica M.
    Vargas-Franco, Dorianmarie
    Hansen, Peter J.
    BIOLOGY OF REPRODUCTION, 2017, 96 (05) : 948 - 959
  • [28] Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment
    Jiang, Zhongyi
    Xing, Changchang
    Wang, Pusen
    Liu, Xueni
    Zhong, Lin
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [29] Osteoblasts change the expression of dysadherin and chemokine (C-C motif) ligand 2 in renal carcinoma cells and increase their motilith
    Schueler, Yvonne
    Aicher, Wilhelm K.
    Klein, Gerd
    CLINICAL & EXPERIMENTAL METASTASIS, 2011, 28 (02) : 175 - 176
  • [30] C-C Motif Ligand 21/C-C Motif Chemokine Receptor 7 Modulated Tumor Properties for Non-Small Cell Lung Cancer Brain Metastasis Patients
    Li, Y. W.
    He, Feng
    Liu, Shuang
    Zhang, Yu
    Li, Ling
    Wang, Bin
    Lan, Lan
    Pan, Z. Y.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 28 - 35